These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28615463)

  • 21. [Wnt-beta-catenin signaling in bone metabolism].
    Urano T
    Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signaling control of bone cell apoptosis.
    Bodine PV
    Cell Res; 2008 Feb; 18(2):248-53. PubMed ID: 18212734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal cells for skeletal tissue engineering.
    Panetta NJ; Gupta DM; Quarto N; Longaker MT
    Panminerva Med; 2009 Mar; 51(1):25-41. PubMed ID: 19352307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt signaling and osteoblastogenesis.
    Bodine PV; Komm BS
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and physiologic function of the low-density lipoprotein receptor.
    Jeon H; Blacklow SC
    Annu Rev Biochem; 2005; 74():535-62. PubMed ID: 15952897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin rising--the bone, brain, bowel connection.
    Rosen CJ
    N Engl J Med; 2009 Mar; 360(10):957-9. PubMed ID: 19264685
    [No Abstract]   [Full Text] [Related]  

  • 27. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
    Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid phenotyping of knockout mice to identify genetic determinants of bone strength.
    Freudenthal B; Logan J; ; Croucher PI; Williams GR; Bassett JH
    J Endocrinol; 2016 Oct; 231(1):R31-46. PubMed ID: 27535945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton.
    Koay MA; Brown MA
    Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cellular basis of metabolic bone disease.
    Rasmussen H; Bordier P
    N Engl J Med; 1973 Jul; 289(1):25-32. PubMed ID: 4575395
    [No Abstract]   [Full Text] [Related]  

  • 32. LRP receptor family member associated bone disease.
    Lara-Castillo N; Johnson ML
    Rev Endocr Metab Disord; 2015 Jun; 16(2):141-8. PubMed ID: 26048454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRP4 in neuromuscular junction and bone development and diseases.
    Shen C; Xiong WC; Mei L
    Bone; 2015 Nov; 80():101-108. PubMed ID: 26071838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of endocytosis and signal transduction by lipoprotein receptors.
    May P; Bock HH; Herz J
    Sci STKE; 2003 Apr; 2003(176):PE12. PubMed ID: 12671190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of bone repair and regeneration.
    Deschaseaux F; Sensébé L; Heymann D
    Trends Mol Med; 2009 Sep; 15(9):417-29. PubMed ID: 19740701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender specific LRP5 influences on trabecular bone structure and strength.
    Dubrow SA; Hruby PM; Akhter MP
    J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocytic receptor-mediated control of morphogen signaling.
    Willnow TE; Christ A; Hammes A
    Development; 2012 Dec; 139(23):4311-9. PubMed ID: 23132241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The LDL receptor family].
    Meilinger M
    Orv Hetil; 2002 Dec; 143(52):2859-65. PubMed ID: 12638312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.